@InsightGenetics

We are a molecular diagnostics company that is working to enhance the diagnosis, monitoring and treatment of cancer. https://xitter.cf/t.co/kbleWYzzWG

 Nashville TN
insightgenetics.com/
Joined January 2013
  • Tweets122
  • Following229
  • Followers114
5Media
"We believe Insight TNBCtype can further enable clinical trial testing and ultimately become the standard of care for TNBC patients bringing TNBC into the age of precision medicine.” - Eric Dahlhauser, Insight Genetics CEO insightgenetics.com/news
Did you know molecular profiling is integral to developing treatments for #TNBC? Learn more about triple negative breast cancer here: bit.ly/2SpmjPr #moleculardiagnostics #breastcancer #precisionmedicine
1
Identifying #TNBC biomarkers can advance targeted drug development. Insight TNBCtype categorizes TNBC tumors into molecular subtypes. bit.ly/2PfSWgw #targetedtherapies #breastcancer
1
Thank you @SABCSSanAntonio for a wonderful conference highlighting some of the most important work in cancer diagnostics and treatment. Already looking forward to 2019! #SABCS18 #breastcancer #bcsm #TNBC
2
4
Thanks Dr. Sharma from @KUMedCenter for explaining the longterm outcomes of #TNBC for adjuvant AC chemotherapy patients. #SABCS18 #bcsm bit.ly/2zC4uWg
2
Important insight from Dr. Musuda from @MDAndersonNews on #TNBC tumor samples at #SABCS18. bit.ly/2zC4uWg
2
5
Check out Poster #P4-08-06 on the impact of molecular subtypes on long-term outcomes in #TNBC patients treated with adjuvant AC #chemotherapy #SABCS18 #TNBC #targetedtherapies #bcsm
The @TNBCFoundation hosted a meeting at the San Antonio Breast Cancer Symposium dedicated exclusively to TNBC. An update from the #SABCS is now available online for our TNBC community. Read more at: ow.ly/HVjj30mTtWV
2
3
Check out abstracts #P4-02-05 and #P4-08-06 about #TNBC at tomorrow's Poster Sessions from 7-9 am in Hall 1! #SABCS18 #bcsm
Are you at #SABCS18? Come to Poster Session 4 on 12/7 to learn how we're advancing #TNBC diagnostics and therapeutics
In many ways, #TNBC is the last frontier in breast cancer, as there are currently no targeted therapeutics available for this population. We’re working to change that with Insight TNBCtype™. bit.ly/2PfSWgw #targetedtherapy #precisionmedicine bit.ly/2zC4uWg
Excited for the #SABC18 Poster Session 4 on Friday. Insight TNBCtype will be included in two posters - one from @KUMedCenter and one from @MDAndersonNews. #bcsm #targetedtherapies #TNBC
2
Insight TNBCtype has the potenial to accelerate #clinicalresearch and advance #targetedtherapies for triple negative breast cancer. #TNBC #bcsm bit.ly/2PfSWgw
1
Insight Genetics Inc retweeted
SWOG Cancer Research Network@SWOG4 Dec 2018
@SWOG investigators present three breast cancer studies at #SABCS18. Public-powered cancer research! @theNCI #BeatCancerWithResearch bit.ly/2SrbdJF via @SWOG @EurekAlert
1
1
We're following @MedscapeOnc for regular news updates from #SABC18. #bcsm #oncology medscape.com/viewcollection/…
Insight Genetics Inc retweeted
Julie Gralow@jrgralow4 Dec 2018
Up next - our session on late recurrence in ER+ breast cancer - w/ M Ellis, M Dowsett, L Chodash #SABCS18
1
9
2
40
We are dedicated to improving the lives of cancer patients through advanced molecular diagnostics that enable precision cancer care. We're ready for this year's #SABCS18! #precisionmedicine #bcsm #TNBC
1
Insight Genetic contributed to two posters at #SABCS18 that showcase findings from the use of Insight TNBCtype! Stop by poster session #4 on Friday! #TNBC #bcsm
1
Insight TNBCtype is a new test that categorizes triple negative breast cancer tumors into distinct molecular subtypes. #breastcancer #bcsm #TNBC bit.ly/2PfSWgw
We'll be at #SABCS18 tomorrow and are looking forward to the presentations and connecting with collaborators. #TNBC #bcsm sabcs.org/2018-SABCS-sup-sup
1
Load more